The pathological consequences of exposure to the vaccine strain Brucella abortus S19 were evaluated in 30 employees from vaccine-manufacturing plants. Active brucellosis was diagnosed in 21 subjects, of whom only five recalled an accidental exposure. Clinical manifestations were mild, and only one patient presented a complication. After antimicrobial therapy, initially symptomatic patients either experienced clinical remission or had mild persistent symptoms. This is the first study reporting infection by B. abortus S19 among workers from vaccine-manufacturing plants, which in many cases was acquired from unnoticed exposures. Measures to improve the safety of B. abortus S19 handling should be implemented. © 2008 The Authors Journal Compilation © 2008 European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Wallach, J. C., Ferrero, M. C., Victoria Delpino, M., Fossati, C. A., & Baldi, P. C. (2008). Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clinical Microbiology and Infection. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1469-0691.2008.02029.x
Mendeley helps you to discover research relevant for your work.